Merck KGaA (OTCMKTS:MKGAF – Get Free Report) and Nuvalent (NASDAQ:NUVL – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, profitability, risk and institutional ownership. Analyst Recommendations This is a breakdown of current ratings […]
Merck KGaA (OTCMKTS:MKGAF – Get Free Report) and Nuvalent (NASDAQ:NUVL – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation. Insider & Institutional Ownership 0.1% of Merck KGaA shares […]
Merck KGaA (OTCMKTS:MKGAF – Get Free Report) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 499,700 shares, an increase of 25.6% from the October 31st total of 397,900 shares. Based on an average trading volume of 4,600 shares, the days-to-cover ratio is […]
Merck KGaA (OTCMKTS:MKGAF – Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $171.62 and traded as high as $173.93. Merck KGaA shares last traded at $173.93, with a volume of 1,517 shares traded. Merck KGaA Trading Up 1.1 % […]
Merck KGaA (OTCMKTS:MKGAF – Get Free Report) saw a large increase in short interest in the month of July. As of July 15th, there was short interest totalling 377,200 shares, an increase of 20.3% from the June 30th total of 313,600 shares. Based on an average daily trading volume, of 6,800 shares, the days-to-cover ratio […]